Covid -19: Moderna vaccine guarantees protection longer than Pfizer/BioNTech – CDC study

Moderna's vaccine produced higher antibodies levels than Pfizer's and J&J's for an essential part of the coronavirus "spike" protein, which is used to invade cells.

RIO DE JANEIRO, BRAZIL - A new study published Friday, 17, by the U.S. Centers for Disease Control and Prevention (CDC) is the latest to suggest that Moderna's Covid-19 vaccine confers greater long-term protection against hospitalization than Pfizer's.

Over the entire period, between March 11 and August 15, 2021 - the period leading up to and including the peak of the delta variant - Moderna's vaccine was 93% effective against hospitalization, Pfizer's was 88%, and J&J's was 68%.

CDC researchers analyzed nearly 3,689 adults who were hospitalized with severe covid-19 between . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?